Parametriline
Parametriline is a synthetic compound that belongs to the class of tricyclic antidepressants. It was developed in the 1960s and was initially marketed under the brand name Parnate. The drug is structurally related to imipramine and has a similar mechanism of action, primarily by inhibiting the reuptake of serotonin and norepinephrine in the brain.
Parametriline is primarily used for the treatment of major depressive disorder, as well as for the management
Like other tricyclic antidepressants, parametriline has several side effects, including dry mouth, constipation, dizziness, and blurred
Parametriline is generally considered to be less effective than newer antidepressants, such as selective serotonin reuptake